Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series

• Main Authors: Lajthia E (Author), Bucheit JD (Author), Nadpara PA (Author), Dixon DL (Author), Caldas LM (Author), Murchie M (Author), Sisson EM (Author)
• Format: Book
• Published: Centro de Investigaciones y Publicaciones Farmaceuticas, 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: National treatment guidelines recommend glucagon-like peptide receptor agonists (GLP-1 RAs) as add-on therapy to oral agents. However, GLP-1 RAs in combination with dipeptidyl peptidase-4 (DPP-4) inhibitors is not recommended due to a lack of evidence. Objective: This case series aims to...